(Q46856126)

25 December 2017

title

Combining endocrine agents with chemotherapy: which patients and what sequence? (English)

1 reference

25 December 2017

1 reference

Kathleen I. Pritchard

object named as

Kathleen I Pritchard

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 February 2008

1 reference

25 December 2017

published in

Cancer

1 reference

25 December 2017

volume

112

1 reference

25 December 2017

issue

3 Suppl

1 reference

25 December 2017

page(s)

718-722

1 reference

25 December 2017

Effects of nandrolone decanoate on the toxicity and anti-tumour action of CCNU and FU in murine tumours

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Aust

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Treatment of metastatic breast cancer in estrogen receptor positive patients. A randomized trial comparing tamoxifen alone versus tamoxifen plus CMF

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy. A study by cancer and leukemia group B

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

A randomized trial of chemotherapy and hormonal therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Randomized evaluation of combination chemotherapy vs. observation alone following response or stabilization after oophorectomy for metastatic breast cancer in premenopausal women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Combined chemo- and hormonal therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer: A prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Chemoendocrine therapy vs chemotherapy alone for advanced breast cancer in postmenopausal women: Preliminary report of a randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Combined cytotoxic and progestogen therapy for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Chemotherapy versus chemotherapy plus hormonotherapy in postmenopausal advanced breast cancer patients a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the Nationa

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23189

7 January 2021

Identifiers

DOI

10.1002/CNCR.23189

1 reference

25 December 2017

1 reference

25 December 2017